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Starting in the DSM-5, both drug and gambling addictions are discussed in a single 12 
chapter, entitled ‘Substance-Related and Addictive Disorders’. The next version of the World 13 
Health Organization’s International Classification of Diseases (ICD-11), which is due to be 14 
released in 2022, also classifies gambling as an addiction and goes further by categorizing 15 
where the maladaptive behavior occurs – predominately ‘offline’ or ‘online’. Such descriptions 16 
mark changes from earlier versions of these publications, in which gambling was considered an 17 
impulse control disorder, rather than an addiction (DSM-IV & ICD-10). The convergent evolution 18 
of how these conditions are defined and diagnosed is primarily supported by recent research 19 
outlining how the development, expression, and effective treatment of drug and gambling 20 
addictions share similar biopsychosocial underpinnings. Yet, there are some crucial differences 21 
between drug use and gambling disorders that require further investigation.  22 
This special topic issue of Progress in Neuro-Psychopharmacology and Biological 23 
Psychiatry explores novel common (and divergent) pathways linking gambling and drug 24 
addictions, through empirical reports and critical reviews, human and animal studies, and 25 
assessments of psychological and neuronal mechanisms. The goals of this special issue are to 26 
integrate developments in these diverse areas of study, to raise the possibility of unified 27 
treatments for addiction, and to provide a deeper understanding of how altered biological 28 
pathways (e.g., mesocorticolimbic, neuroendocrine) contribute to psychological and behavioral 29 
dysfunction. 30 
 In this issue, Grant and Chamberlain (2020) compare clinical similarities and differences 31 
between gambling disorder (GD) and substance use disorders (SUDs). They describe how 32 
people with either of these conditions may have difficulty inhibiting or controlling their behavior, 33 
which is characteristic of high levels of impulsivity and risk-taking (Grant and Chamberlain, 34 
2020). Grant and Chamberlain mention, however, that while there may be substantial overlap 35 
between GD and SUDs, the biopsychosocial underpinnings of these disorders can vary across 36 
individuals. It is believed that comorbidity between mental health conditions may account for 37 
some of this individual variation (Balodis and Potenza, 2020; Grant and Chamberlain, 2020). 38 
Such variation in behavior is also seen in animal models, which are highlighted in several 39 
articles in this special issue (Anselme and Robinson, 2020; Oggiano et al., 2020; Orsini et al., 40 
2020). For example, Orsini et al. (2020) demonstrate that rats exhibiting heightened risk-taking 41 
are more likely to escalate drug-pursuit (during long-access drug self-administration), compared 42 
to animals that are risk-averse. Conversely, using a rat gambling task and pharmacologic 43 
magnetic resonance imaging (phMRI), Oggiano et al. (2020) report decreases in the pursuit of 44 
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uncertain options in a subset of animals that show ADHD-like behaviors; this finding was 45 
accompanied by differential activation in striatal sub-regions. 46 
In their review article, Balodis and Potenza (2020) suggest that reduced inhibitory control 47 
over behavior by the medial prefrontal (mPFC) and dorsal anterior cingulate (dACC) cortices 48 
can contribute to substance use and gambling addictions. Blunted behavioral regulation may be 49 
a consequence of how strongly drug- or gambling-related cues can alter mPFC/dACC activity 50 
(Balodis and Potenza, 2020). Another region that is often ‘turned on’ by reward-associated cues 51 
is the nucleus accumbens (NAc; Linnet, 2020; Zack et al., 2020), a region of the ventral striatum 52 
that receives dopaminergic input from the ventral tegmental area (VTA). Excitation of the NAc 53 
may be associated with elevated craving for reward (Balodis and Potenza, 2020) and the 54 
activity of the NAc itself can be modulated by a variety of brain regions (e.g., mPFC and 55 
amygdala). For example, in this special issue van Holstein et al. (2020) demonstrate how 56 
disconnecting the basolateral amygdala from the NAc results in suboptimal decision-making in 57 
rodents during a gambling task. 58 
Two articles in the special issue discuss the role of dopamine in the NAc for drug use 59 
and gambling disorders (Linnet, 2020; Zack et al., 2020). Both articles explain how dopamine 60 
neurotransmission may facilitate learning about stimuli that predict reward (either for drugs or 61 
monetary gain). As discussed above, there is individual variation in behavior and neurochemical 62 
responses observed in individuals with a SUD or GD. Some individuals, for example, may 63 
display an exaggerated response to reward-associated cues. This can take the form of 64 
excessive approach (‘sign-tracking’) to the cue itself, enhanced motivation evoked by cue 65 
exposure, and significant dopamine release after experiencing a cue (Anselme and Robinson, 66 
2020). 67 
 It can be challenging to compare the brain responses directly caused by drugs with the 68 
receipt of monetary rewards in gambling. This is because the pharmacological action of some 69 
substances is to enhance dopamine transmission in the NAc; this can also result in long-lasting 70 
brain plasticity. For example, repeated exposure to drugs can enhance (sensitize) the ability of 71 
the drug to increase dopamine release in the NAc (Linnet, 2020). At the same time, 72 
hypoactivation of certain brain regions may be observed in the absence of drug or drug cues 73 
(Linnet, 2020; as argued by Leyton and Vezina, 2014). Furthermore, as demonstrated by 74 
Robinson et al. in this special issue, sensitization produced by repeated exposure to drugs of 75 
abuse can bias an individual’s attraction towards cues that are highly predictive of reward 76 
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(rather than directing attention to gambling-like stimuli which have less predictive value; 77 
Robinson et al., 2020).  78 
Despite these comparative challenges, intermittent exposure to unpredictable non-drug 79 
reward has been found to sensitize dopamine responsivity in the brain (reviewed by Mascia et 80 
al., 2020). This process might cause cues that are associated with non-drug reward to become 81 
more motivational (Anselme and Robinson (2020) focus on enhanced sign-tracking), thereby 82 
driving gambling-like behavior by instilling a sense of ‘cognitive appetite’ that requires resolution 83 
(Zack et al., 2020). Indeed, in an animal model in which rats are repeatedly and intermittently 84 
exposed to uncertain conditions of non-drug reward, dopamine transmission in the NAc 85 
becomes sensitized, and rats develop addiction-like pursuit of amphetamine (Mascia et al., 86 
2020). Notably, these effects parallel what is observed following exposure to sensitizing drug 87 
regimens (Mascia et al., 2020). Thus, aberrant reward-learning, repeated exposure to 88 
uncertainty, and potential pharmacological effects of drugs can summate in a “constellation of 89 
events [that] can disturb the finely-tuned neurocircuitry that guides adaptive behaviour” (Zack et 90 
al., 2020) by altering dopamine neurotransmission in the brain. 91 
 Thus far we have discussed how exposure to distinct events (e.g., experience with 92 
reward or reward-related cues that are either unpredictable or intermittent) may quickly enhance 93 
dopamine neurotransmission in certain brain regions, thereby exciting certain behaviors or 94 
cognitive states that promote reward-pursuit. The brief spikes in dopamine neurotransmission 95 
caused by such rapid and definable occurrences are often referred to as ‘phasic dopamine 96 
signalling’. In contrast, dopamine neurons are also believed to have another type of activity 97 
state in which they display prolonged, or tonic, levels of action potential firing and subsequent 98 
transmitter release (although, this remains an area of debate; see Hamid et al., 2016). It is 99 
thought that such long-lasting elevations of extracellular dopamine may encourage a state of 100 
vigor in the individual – this could also motivate the pursuit of reward. In this special issue, 101 
Kirschner et al. (2020) describe how vigor related to enhanced tonic dopamine levels is 102 
associated with “compulsive engagement with rewarding stimuli, increased risk taking and 103 
impulsivity”. Such a state, which may be observed in people with psychosis or bipolar disorder, 104 
could lead to substance misuse and problematic gambling (Kirschner et al., 2020). In another 105 
example, when people with Parkinson’s Disease (who have low levels of dopamine) are treated 106 
with certain dopamine-replacement therapies (such as agonists for dopamine D2/D3-type 107 
receptors), there is sometimes an increase in impulsive behaviors, like gambling (Kirschner et 108 
al., 2020; Napier et al., 2020). In this special issue, Napier et al. (2020) suggest that these 109 
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dopamine agonists mimic tonic dopamine neurotransmission in patients, and they highlight 110 
studies demonstrating how this could lead to disadvantageous decision-making (as displayed 111 
during gambling).   112 
 While most research has focused on similarities in dopamine function between SUDs 113 
and GD, the activation or repression of other biological processes are also implicated in these 114 
conditions. For example, in this special issue, Mascia et al. (2020) show that extracellular levels 115 
of glutamate, adenosine, and aspartic acid are also increased in the NAc of rats exposed to 116 
uncertain non-drug reward. The importance of glutamate in the NAc to gambling-like behavior in 117 
rats is also demonstrated by van Holstein et al. (2020), specifically the BLA-NAc shell glutamate 118 
pathway in perturbed decision making. It is reflected as well in rats previously exposed to 119 
repeated intermittent uncertainty by altered levels of several proteins (CaMKII, PKC, ∆FosB, 120 
GLT1) known to regulate glutamate transmission (Mascia et al., 2020). In other brain regions, 121 
levels of the neurotransmitter acetylcholine may help govern attention to reward-associated 122 
stimuli; this may be disrupted in GD and SUD, as shown in the sign-tracking animal model 123 
(Anselme and Robinson, 2020).  124 
Differential hormonal signalling may also contribute to GD and SUDs. In this special 125 
issue, Li et al. (2020) review the contributions of the hypothalamic-pituitary-gonadal (HPG) and 126 
hypothalamic–pituitary–adrenal (HPA) axes to alcohol use disorder and GD. For example, they 127 
describe how testosterone may be enhanced by alcohol use and gambling, while cortisol may 128 
have divergent effects on these behaviors (increasing alcohol consumption and decreasing 129 
gambling; Li et al., 2020). Regardless of these similarities and differences, Li et al. also 130 
emphasize that substantial individual variation exists in hormonal function and that various 131 
psychosocial factors impact desire to gamble or drink alcohol. Furthermore, future studies 132 
should investigate how sex differences uniquely impact biological processes that drive gambling 133 
and drug use.  134 
Finally, there are specific differences between SUDs and GD that are difficult to 135 
reconcile within a unified model of addiction. In essence, these include attempts to recover 136 
monetary losses that result from gambling and high rates of suicidal ideation in gamblers (Grant 137 
and Chamberlain, 2020). Balodis and Potenza, for example, suggest that different brain circuits 138 
are recruited during “loss chasing” tasks performed by gamblers and cocaine-dependent 139 
individuals; such findings indicate that certain behaviors and neural processes are not shared 140 
between these conditions. When considering these findings, it is also important to remember 141 
that few human brain imaging studies directly compare individuals who have a SUD or GD (in 142 
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most examples, separate research projects investigate SUD or GD in comparison to ‘healthy’ 143 
controls). 144 
We started this introduction to our special issue on problematic gambling and drug use 145 
by describing how diagnostic criteria for these conditions are converging – according to the 146 
newest version of the DSM and the updated ICD-11, gambling disorder is categorized as an 147 
addiction along with various substance use disorders. The articles in this special issue largely 148 
support the new diagnostic criteria by providing evidence of similar biopsychosocial 149 
underpinnings of these conditions. While much attention has been placed on the role of 150 
dopamine neurotransmission within the NAc, the articles show that other brain regions and 151 
signalling molecules are also implicated in SUDs and GD, and thus may also serve as 152 
pharmacotherapeutic targets. The studies presented within this special issue also stress how 153 
individuals vary in why they gamble or use drugs, and therefore may require personalized 154 
treatments. Some individual differences, for example, may relate to sex hormone signalling or 155 
comorbidities amongst psychiatric conditions – such variation requires further investigation. 156 
Finally, researchers have observed unique behavioral patterns and cognitive states in people 157 
who pathologically pursue drug or excessively gamble; these differences may be difficult to 158 
reconcile in a unified theory of addiction. Despite these challenges, this collection of articles 159 
provides novel insights into both the shared and divergent features of substance use and 160 
gambling disorders. By bringing together research on SUDs and GD from scientists with unique 161 
specializations and opinions, we believe that this special issue will meaningfully contribute to the 162 
study of addiction, encourage cross-topic collaboration, and positively impact treatment for 163 
these conditions.     164 
 165 
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